OPC 21268
|
|
- CAS-Nr.
- 131631-89-5
- Englisch Name:
- OPC 21268
- Synonyma:
- CS-2724;Fuscoside;OPC 21268;OPC-21268 hydrate;OPC 21268;OPC-21268;OPC21268;Inhibitor,Vasopressin Receptor,OPC21268,Fuscoside,OPC-21268,inhibit;1-[1-[4-(3-Acetylaminopropoxy)benzoyl]-4-piperidyl]-3,4-dihydroquinolin-2(1H)-one;1-{1-[4(3-acetylaminopropoxy)benzoyl]-4-piperidyl}-3,4-dihydro-2(1H)-quinolinone hydrate;N-[3-[4-[4-(2-oxo-3,4-dihydroquinolin-1-yl)piperidine-1-carbonyl]phenoxy]propyl]acetamide;N-[3-[4-[[4-(3,4-Dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]acetamide
- CBNumber:
- CB61356814
- Summenformel:
- C26H31N3O4
- Molgewicht:
- 449.54
- MOL-Datei:
- 131631-89-5.mol
|
OPC 21268 Eigenschaften
- Siedepunkt:
- 772.5±60.0 °C(Predicted)
- Dichte
- 1?+-.0.06 g/cm3(Predicted)
- storage temp.
- 2-8°C
- L?slichkeit
- DMSO: ≥20mg/mL
- pka
- 16.17±0.46(Predicted)
- Aggregatzustand
- powder
- Farbe
- white to off-white
OPC 21268 Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
OPC 21268 is a nonpeptide antagonist of vasopressin V
1 receptors (IC
50 = 0.4 μM in rat liver membranes). It is selective for V
1 over V
2 receptors (IC
50 = >100 μM in kidney membranes). It is also selective for rat over human V
1 receptors (K
is = 25 and 8,800 nM, respectively), which can be partially attributed to the alanine residue at position 337 of the rat sequence, instead of a glycine residue in the human sequence, with differences at positions 224, 310, and 324 also contributing. OPC 21268 (0.03-1 mg/kg, i.v.) inhibits pressor responses induced by arginine vasopressin (argipressin; ) in pithed rats and arginine vasopressin-induced vasoconstriction in conscious rats (ID
50 = 2 mg/kg). It induces hypotension in aged spontaneously hypertensive rats (SHRs) and stroke-prone SHRs when administered at a dose of 3 mg/kg.
Verwenden
OPC 21268 is a nonpeptide AVP (Vasopressin) Receptor V antagonist.
OPC 21268 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
OPC 21268 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 71)Lieferanten
- 1-[1-[4-(3-Acetylaminopropoxy)benzoyl]-4-piperidyl]-3,4-dihydroquinolin-2(1H)-one
- 1-{1-[4(3-acetylaminopropoxy)benzoyl]-4-piperidyl}-3,4-dihydro-2(1H)-quinolinone hydrate
- N-[3-[4-[[4-(3,4-dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]-acetamide hydrate
- OPC-21268 hydrate
- N-[3-[4-[[4-(3,4-Dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]acetamide
- OPC 21268
- N-[3-[4-[4-(2-oxo-3,4-dihydroquinolin-1-yl)piperidine-1-carbonyl]phenoxy]propyl]acetamide
- OPC 21268;OPC-21268;OPC21268
- CS-2724
- Fuscoside
- Acetamide, N-[3-[4-[[4-(3,4-dihydro-2-oxo-1(2H)-quinolinyl)-1-piperidinyl]carbonyl]phenoxy]propyl]-
- Inhibitor,Vasopressin Receptor,OPC21268,Fuscoside,OPC-21268,inhibit
- N-(3-{4-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-1-yl)piperidine-1-carbonyl]phenoxy}propyl)acetamide
- 131631-89-5